51175-07-6 Usage
Description
1-(1-hydroxycyclohexyl)cyclobutanecarboxylic acid is a cyclic compound characterized by the presence of a cyclobutane ring and a cyclohexyl hydroxyl group attached to the carboxylic acid functional group. This unique structure endows the compound with enhanced chemical reactivity and potential biological activity, making it a promising candidate for pharmaceutical and medicinal chemistry applications.
Uses
Used in Pharmaceutical Industry:
1-(1-hydroxycyclohexyl)cyclobutanecarboxylic acid is used as a building block for drug design due to its unique cyclobutane ring and cyclohexyl hydroxyl group, which may contribute to the development of new pharmaceuticals with specific properties and activities.
Used in Medicinal Chemistry:
1-(1-hydroxycyclohexyl)cyclobutanecarboxylic acid is used as a compound with potential applications in medicinal chemistry, where its chemical reactivity and structural features can be exploited to create novel therapeutic agents.
Further research and studies are necessary to fully understand the potential uses and properties of 1-(1-hydroxycyclohexyl)cyclobutanecarboxylic acid, as its current applications are based on its structural characteristics and the possibilities they present in the fields of drug design and medicinal chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 51175-07-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,1,1,7 and 5 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 51175-07:
(7*5)+(6*1)+(5*1)+(4*7)+(3*5)+(2*0)+(1*7)=96
96 % 10 = 6
So 51175-07-6 is a valid CAS Registry Number.
51175-07-6Relevant articles and documents
COMBINATIONS OF HEPATITIS C VIRUS INHIBITORS
-
Page/Page column 627, (2015/02/02)
The present disclosure is generally directed to antiviral compounds, and more specifically directed to combinations of compounds which can inhibit the function of the NS5A protein encoded by Hepatitis C virus (HCV), compositions comprising such combinations, and methods for inhibiting the function of the NS5A protein.
